Cleantech Investing Metamaterial Insiders Convert $368 Thousand of Debt into Equity at a Premium to Market
Pharmaceutical Investing Merck Receives Priority Review From FDA for New Drug Application for HIF-2? Inhibitor Belzutifan
Cannabis Investing Numinus Wellness Inc. Announces Upsized Bought Deal Public Offering to $35 million
Agriculture Investing Canbud Distribution Corporation Continues to Lay Groundwork in Psychedelics Market - Enters into LOI with Molecular Science Corp. for R&D, Testing, and Import
Pharmaceutical Investing Merck to Host Investor Briefing to Discuss Broad HIV Development Program and Newly Announced Collaboration with Gilead
Gilead and Merck Announce Agreement to Jointly Develop and Commercialize Long-Acting, Investigational Treatment Combinations of Lenacapavir and Islatravir in HIV
Aurinia Announces Positive Cost-Effectiveness Assessment of LUPKYNIS in Latest ICER Draft Evidence Report
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain MetastasisÂ
